Myriad Genetics up 5% on positive prenatal screening test data

Findings from a new study, published Ultrasound in Obstetrics and Gynecology, showed a high rate of accuracy for Myriad Genetics’ (MYGN +4.7%) noninvasive Prequel Prenatal Screen test in addition to a low test-failure rate of 1/1,000.

Prequel uses whole-genome sequencing to identify chromosomal abnormalities, including trisomies 13 (associated with intellectual and physical disabilities), 18 (slow growth and physical defects) and 21 (Down syndrome).

Prenatal testing accounted for almost 14% of its FQ1 molecular diagnostic testing revenue ($23.5M/172.0M).

https://seekingalpha.com/news/3517621-myriad-genetics-5-percent-positive-prenatal-screening-test-data